Multidisciplinaire richtlijn Cardiovasculair ... - Diliguide

Anonymus. Randomised trial of cholesterol lowering in 4444 patients with coronary heart
disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
Anonymus. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of
ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329-39.
Anonymus. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after
myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio
della Sopravvivenza nell’Infarto miocardico. Lancet 1999;354:447-55.
Anonymus. Secondary prevention by raising HDL cholesterol and reducing triglycerides in
patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study.
Circulation 2000;102:21-7.
Anonymus. Randomised trial of a perindopril-based blood-pressure-lowering regimen
among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet
2001;358:1033-41.
Anonymus. Collaborative meta-analysis of randomised trials of antiplatelet therapy for
prevention of death, myocardial infarction, and stroke in high risk patients. BMJ
2002a;324:71-86.
Anonymus. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in
20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002b;360:7-22.
Anonymus. 2003 European Society of Hypertension-European Society of Cardiology
guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
Anonymus. ADVANCE trial of great importance in preventing cardiovascular deaths in type 2
diabetes. Cardiovasc J Afr 2007;18:343-4.
Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes:
review with meta-analysis of clinical studies. J Am Coll Nutr 2003;22:331-9.
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of
the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N
Engl J Med 1997;336:1117-24.
Armitage J. The safety of statins in clinical practice. Lancet 2007;370:1781-90.
Armitage J, Bowman L, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, et al. Intensive
lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors
of myocardial infarction: a double-blind randomised trial. Lancet 2010;376:1658-69.
Asberg A. Interactions between cyclosporin and lipid-lowering drugs: implications for organ
transplant recipients. Drugs 2003;63:367-78.
Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, et al. A prospective
study of nutritional factors and hypertension among US men. Circulation 1992;86:1475-84.
Ashenden R, Silagy C, Weller D. A systematic review of the effectiveness of promoting lifestyle
change in general practice. Fam Pract 1997;14:160-76.
Asp NG, Björntorp P, Britton M, Carlsson P, Kjellstrom T, Marcus C. Obesity - problems and
interventions. A systematic review (2002). Stockholm: The Swedish Council on Technology
Assessment in Health Care (SBU), 2002.
MULTIDISCIPLINAIRE RICHTLIJN CARDIOVASCULAIR RISICOMANAGEMENT 110